Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,982
archived clinical trials in
Endocrine

Safety Study of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism
An Open Label, Escalating Dose, 6 Month Phase III Safety Study Of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism
Status: Enrolling
Updated:  6/12/2012
Clinical Research Facility
mi
from
Phoenix, AZ
Safety Study of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism
An Open Label, Escalating Dose, 6 Month Phase III Safety Study Of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism
Status: Enrolling
Updated: 6/12/2012
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Safety Study of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism
An Open Label, Escalating Dose, 6 Month Phase III Safety Study Of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism
Status: Enrolling
Updated:  6/12/2012
Clinical Research Facility
mi
from
Santa Clara, CA
Safety Study of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism
An Open Label, Escalating Dose, 6 Month Phase III Safety Study Of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism
Status: Enrolling
Updated: 6/12/2012
Clinical Research Facility
mi
from
Santa Clara, CA
Click here to add this to my saved trials
Safety Study of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism
An Open Label, Escalating Dose, 6 Month Phase III Safety Study Of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism
Status: Enrolling
Updated:  6/12/2012
Clinical Research Facility
mi
from
Aurora, CO
Safety Study of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism
An Open Label, Escalating Dose, 6 Month Phase III Safety Study Of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism
Status: Enrolling
Updated: 6/12/2012
Clinical Research Facility
mi
from
Aurora, CO
Click here to add this to my saved trials
Safety Study of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism
An Open Label, Escalating Dose, 6 Month Phase III Safety Study Of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism
Status: Enrolling
Updated:  6/12/2012
Clinical Research Facility
mi
from
Daytona Beach, FL
Safety Study of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism
An Open Label, Escalating Dose, 6 Month Phase III Safety Study Of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism
Status: Enrolling
Updated: 6/12/2012
Clinical Research Facility
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
Safety Study of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism
An Open Label, Escalating Dose, 6 Month Phase III Safety Study Of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism
Status: Enrolling
Updated:  6/12/2012
Clinical Research Facility
mi
from
Baltimore, MD
Safety Study of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism
An Open Label, Escalating Dose, 6 Month Phase III Safety Study Of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism
Status: Enrolling
Updated: 6/12/2012
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Safety Study of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism
An Open Label, Escalating Dose, 6 Month Phase III Safety Study Of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism
Status: Enrolling
Updated:  6/12/2012
Clinical Research Facility
mi
from
Newark, NJ
Safety Study of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism
An Open Label, Escalating Dose, 6 Month Phase III Safety Study Of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism
Status: Enrolling
Updated: 6/12/2012
Clinical Research Facility
mi
from
Newark, NJ
Click here to add this to my saved trials
Safety Study of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism
An Open Label, Escalating Dose, 6 Month Phase III Safety Study Of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism
Status: Enrolling
Updated:  6/12/2012
Clinical Research Facility
mi
from
Dallas, TX
Safety Study of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism
An Open Label, Escalating Dose, 6 Month Phase III Safety Study Of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism
Status: Enrolling
Updated: 6/12/2012
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Safety Study of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism
An Open Label, Escalating Dose, 6 Month Phase III Safety Study Of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism
Status: Enrolling
Updated:  6/12/2012
Clinical Research Facility
mi
from
Salt Lake City, UT
Safety Study of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism
An Open Label, Escalating Dose, 6 Month Phase III Safety Study Of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism
Status: Enrolling
Updated: 6/12/2012
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Resveratrol-Leucine Metabolite Synergy in Pre-diabetes
Resveratrol-Leucine Metabolite Synergy in Pre-diabetes
Status: Enrolling
Updated:  6/21/2012
Facility: Vanderbilt University
mi
from
Nashville, TN
Resveratrol-Leucine Metabolite Synergy in Pre-diabetes
Resveratrol-Leucine Metabolite Synergy in Pre-diabetes
Status: Enrolling
Updated: 6/21/2012
Facility: Vanderbilt University
mi
from
Nashville, TN
Click here to add this to my saved trials
Pilot Study of a Multi-Drug Regimen for Severe Pulmonary Fibrosis in Hermansky-Pudlak Syndrome
Pilot Study of a Multi-Drug Regimen for Severe Pulmonary Fibrosis in Hermansky-Pudlak Syndrome
Status: Enrolling
Updated:  7/6/2012
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Pilot Study of a Multi-Drug Regimen for Severe Pulmonary Fibrosis in Hermansky-Pudlak Syndrome
Pilot Study of a Multi-Drug Regimen for Severe Pulmonary Fibrosis in Hermansky-Pudlak Syndrome
Status: Enrolling
Updated: 7/6/2012
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
N-Acetylcysteine and Milk Thistle for Treatment of Diabetic Nephropathy
N-Acetylcysteine and Milk Thistle for Treatment of Diabetic Nephropathy.
Status: Enrolling
Updated:  7/10/2012
University of Texas Hlth Sci Ctr San Ant
mi
from
San Antonio, TX
N-Acetylcysteine and Milk Thistle for Treatment of Diabetic Nephropathy
N-Acetylcysteine and Milk Thistle for Treatment of Diabetic Nephropathy.
Status: Enrolling
Updated: 7/10/2012
University of Texas Hlth Sci Ctr San Ant
mi
from
San Antonio, TX
Click here to add this to my saved trials
Mindfulness Based Cognitive Therapy for Chronic Pain and Comorbid Unipolar Depression
Mindfulness Based Cognitive Therapy for Chronic Pain and Comorbid Unipolar Depression
Status: Enrolling
Updated:  7/12/2012
MGH Depression Clinical and Research Program
mi
from
Boston, MA
Mindfulness Based Cognitive Therapy for Chronic Pain and Comorbid Unipolar Depression
Mindfulness Based Cognitive Therapy for Chronic Pain and Comorbid Unipolar Depression
Status: Enrolling
Updated: 7/12/2012
MGH Depression Clinical and Research Program
mi
from
Boston, MA
Click here to add this to my saved trials
Comparative Effects of 2 Diets in Veterans With the Metabolic Syndrome
Comparative Effects of Two Popular Diets in Veterans With the Metabolic Syndrome
Status: Enrolling
Updated:  7/13/2012
VA Maryland Health Care System, Baltimore
mi
from
Baltimore, MD
Comparative Effects of 2 Diets in Veterans With the Metabolic Syndrome
Comparative Effects of Two Popular Diets in Veterans With the Metabolic Syndrome
Status: Enrolling
Updated: 7/13/2012
VA Maryland Health Care System, Baltimore
mi
from
Baltimore, MD
Click here to add this to my saved trials
Aggressive Versus Moderate Glycemic Control in Diabetic Coronary Bypass Patients
Impact of Aggressive Versus Moderate Glycemic Control on Clinical Outcomes Following Coronary Artery Bypass Graft Surgery in Diabetic Patients
Status: Enrolling
Updated:  7/17/2012
Boston Med Center
mi
from
Boston, MA
Aggressive Versus Moderate Glycemic Control in Diabetic Coronary Bypass Patients
Impact of Aggressive Versus Moderate Glycemic Control on Clinical Outcomes Following Coronary Artery Bypass Graft Surgery in Diabetic Patients
Status: Enrolling
Updated: 7/17/2012
Boston Med Center
mi
from
Boston, MA
Click here to add this to my saved trials
Re-differentiation of Radioiodine-Refractory BRAF V600E-mutant Papillary Thyroid Carcinoma With GSK2118436
Re-differentiation of Radioiodine-Refractory BRAF V600E-mutant Papillary Thyroid Carcinoma With GSK2118436
Status: Enrolling
Updated:  8/2/2012
Massachusetts General Hospital
mi
from
Boston, MA
Re-differentiation of Radioiodine-Refractory BRAF V600E-mutant Papillary Thyroid Carcinoma With GSK2118436
Re-differentiation of Radioiodine-Refractory BRAF V600E-mutant Papillary Thyroid Carcinoma With GSK2118436
Status: Enrolling
Updated: 8/2/2012
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
High Protein and Exercise Therapy Plus Nocturnal Enteral Feeding in Juvenile-onset Pompe Disease
High Protein Nutrition and Exercise Therapy (HPET) Plus Nocturnal Enteral Feeding (NEF) in Juvenile-onset Pompe Disease.
Status: Enrolling
Updated:  8/2/2012
Columbia University Medical Center
mi
from
New York, NY
High Protein and Exercise Therapy Plus Nocturnal Enteral Feeding in Juvenile-onset Pompe Disease
High Protein Nutrition and Exercise Therapy (HPET) Plus Nocturnal Enteral Feeding (NEF) in Juvenile-onset Pompe Disease.
Status: Enrolling
Updated: 8/2/2012
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Reduced Intensity Conditioning for Umbilical Cord Blood Transplant in Pediatric Patients With Non-Malignant Disorders
A Pilot Study of Reduced Intensity Conditioning in Pediatric Patients <21 Years of Age With Non-Malignant Disorders Undergoing Umbilical Cord Blood Transplantation
Status: Enrolling
Updated:  8/5/2012
Duke University Medical Center Pediatric Blood and Marrow Transplant Program
mi
from
Durham, NC
Reduced Intensity Conditioning for Umbilical Cord Blood Transplant in Pediatric Patients With Non-Malignant Disorders
A Pilot Study of Reduced Intensity Conditioning in Pediatric Patients <21 Years of Age With Non-Malignant Disorders Undergoing Umbilical Cord Blood Transplantation
Status: Enrolling
Updated: 8/5/2012
Duke University Medical Center Pediatric Blood and Marrow Transplant Program
mi
from
Durham, NC
Click here to add this to my saved trials
Isocaloric Dietary Interventions for Insulin Resistance and the Metabolic Syndrome
Isocaloric Dietary Interventions for Insulin Resistance and the Metabolic Syndrome
Status: Enrolling
Updated:  8/8/2012
Rockefeller University
mi
from
New York, NY
Isocaloric Dietary Interventions for Insulin Resistance and the Metabolic Syndrome
Isocaloric Dietary Interventions for Insulin Resistance and the Metabolic Syndrome
Status: Enrolling
Updated: 8/8/2012
Rockefeller University
mi
from
New York, NY
Click here to add this to my saved trials
Characterization of the Variability Of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Prediabetes
Characterization of the Variability Of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Prediabetes
Status: Enrolling
Updated:  8/9/2012
ICON Development Solutions, Gault Lane
mi
from
San Antonio, TX
Characterization of the Variability Of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Prediabetes
Characterization of the Variability Of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Prediabetes
Status: Enrolling
Updated: 8/9/2012
ICON Development Solutions, Gault Lane
mi
from
San Antonio, TX
Click here to add this to my saved trials
Reacquisition of Radioactive Iodine (RAI) Uptake of RAI-Refractory Metastatic Thyroid Cancers by Pretreatment With the Selective MEK Inhibitor AZD6244
Reacquisition of RAI Uptake of RAI-Refractory Metastatic Thyroid Cancers by Pretreatment With the Selective MEK Inhibitor AZD6244: A Pilot Study
Status: Enrolling
Updated:  8/17/2012
Memorial Sloan-Kettering Cancer Center
mi
from
New York, NY
Reacquisition of Radioactive Iodine (RAI) Uptake of RAI-Refractory Metastatic Thyroid Cancers by Pretreatment With the Selective MEK Inhibitor AZD6244
Reacquisition of RAI Uptake of RAI-Refractory Metastatic Thyroid Cancers by Pretreatment With the Selective MEK Inhibitor AZD6244: A Pilot Study
Status: Enrolling
Updated: 8/17/2012
Memorial Sloan-Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Melatonin and the Metabolic Syndrome
Melatonin Supplementation and the Metabolic Syndrome: A Phase II Crossover Design Clinical Trial
Status: Enrolling
Updated:  9/6/2012
Emory University
mi
from
Atlanta, GA
Melatonin and the Metabolic Syndrome
Melatonin Supplementation and the Metabolic Syndrome: A Phase II Crossover Design Clinical Trial
Status: Enrolling
Updated: 9/6/2012
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Evaluation of a Lifestyle Intervention for Employees With Prediabetes
Evaluation of a Lifestyle Intervention for Employees With Prediabetes
Status: Enrolling
Updated:  9/7/2012
Ohio State University
mi
from
Columbus, OH
Evaluation of a Lifestyle Intervention for Employees With Prediabetes
Evaluation of a Lifestyle Intervention for Employees With Prediabetes
Status: Enrolling
Updated: 9/7/2012
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Phase III Study to Evaluated Morning Testosterone Normalization in Overweight Men Less Than 60 Years of Age With Secondary Hypogonadism
A Randomized, Double Blind, Placebo Controlled Multi-Center Phase III Study to Evaluate Normalization of Morning Testosterone Levels in Overweight Men With Acquired Hypogonadotropic Hypogonadism and Normal Sperm Concentration
Status: Enrolling
Updated:  9/16/2012
Clinical Research Facility
mi
from
Birmingham, AL
Phase III Study to Evaluated Morning Testosterone Normalization in Overweight Men Less Than 60 Years of Age With Secondary Hypogonadism
A Randomized, Double Blind, Placebo Controlled Multi-Center Phase III Study to Evaluate Normalization of Morning Testosterone Levels in Overweight Men With Acquired Hypogonadotropic Hypogonadism and Normal Sperm Concentration
Status: Enrolling
Updated: 9/16/2012
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Phase III Study to Evaluated Morning Testosterone Normalization in Overweight Men Less Than 60 Years of Age With Secondary Hypogonadism
A Randomized, Double Blind, Placebo Controlled Multi-Center Phase III Study to Evaluate Normalization of Morning Testosterone Levels in Overweight Men With Acquired Hypogonadotropic Hypogonadism and Normal Sperm Concentration
Status: Enrolling
Updated:  9/16/2012
Clinical Research Facility
mi
from
Fort Smith, AR
Phase III Study to Evaluated Morning Testosterone Normalization in Overweight Men Less Than 60 Years of Age With Secondary Hypogonadism
A Randomized, Double Blind, Placebo Controlled Multi-Center Phase III Study to Evaluate Normalization of Morning Testosterone Levels in Overweight Men With Acquired Hypogonadotropic Hypogonadism and Normal Sperm Concentration
Status: Enrolling
Updated: 9/16/2012
Clinical Research Facility
mi
from
Fort Smith, AR
Click here to add this to my saved trials
Phase III Study to Evaluated Morning Testosterone Normalization in Overweight Men Less Than 60 Years of Age With Secondary Hypogonadism
A Randomized, Double Blind, Placebo Controlled Multi-Center Phase III Study to Evaluate Normalization of Morning Testosterone Levels in Overweight Men With Acquired Hypogonadotropic Hypogonadism and Normal Sperm Concentration
Status: Enrolling
Updated:  9/16/2012
Clinical Research Facility
mi
from
Santa Clara, CA
Phase III Study to Evaluated Morning Testosterone Normalization in Overweight Men Less Than 60 Years of Age With Secondary Hypogonadism
A Randomized, Double Blind, Placebo Controlled Multi-Center Phase III Study to Evaluate Normalization of Morning Testosterone Levels in Overweight Men With Acquired Hypogonadotropic Hypogonadism and Normal Sperm Concentration
Status: Enrolling
Updated: 9/16/2012
Clinical Research Facility
mi
from
Santa Clara, CA
Click here to add this to my saved trials
Phase III Study to Evaluated Morning Testosterone Normalization in Overweight Men Less Than 60 Years of Age With Secondary Hypogonadism
A Randomized, Double Blind, Placebo Controlled Multi-Center Phase III Study to Evaluate Normalization of Morning Testosterone Levels in Overweight Men With Acquired Hypogonadotropic Hypogonadism and Normal Sperm Concentration
Status: Enrolling
Updated:  9/16/2012
Clinical Research Facility
mi
from
Daytona Beach, FL
Phase III Study to Evaluated Morning Testosterone Normalization in Overweight Men Less Than 60 Years of Age With Secondary Hypogonadism
A Randomized, Double Blind, Placebo Controlled Multi-Center Phase III Study to Evaluate Normalization of Morning Testosterone Levels in Overweight Men With Acquired Hypogonadotropic Hypogonadism and Normal Sperm Concentration
Status: Enrolling
Updated: 9/16/2012
Clinical Research Facility
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
Phase III Study to Evaluated Morning Testosterone Normalization in Overweight Men Less Than 60 Years of Age With Secondary Hypogonadism
A Randomized, Double Blind, Placebo Controlled Multi-Center Phase III Study to Evaluate Normalization of Morning Testosterone Levels in Overweight Men With Acquired Hypogonadotropic Hypogonadism and Normal Sperm Concentration
Status: Enrolling
Updated:  9/16/2012
Clinical Research Facility
mi
from
Louisville, KY
Phase III Study to Evaluated Morning Testosterone Normalization in Overweight Men Less Than 60 Years of Age With Secondary Hypogonadism
A Randomized, Double Blind, Placebo Controlled Multi-Center Phase III Study to Evaluate Normalization of Morning Testosterone Levels in Overweight Men With Acquired Hypogonadotropic Hypogonadism and Normal Sperm Concentration
Status: Enrolling
Updated: 9/16/2012
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
Phase III Study to Evaluated Morning Testosterone Normalization in Overweight Men Less Than 60 Years of Age With Secondary Hypogonadism
A Randomized, Double Blind, Placebo Controlled Multi-Center Phase III Study to Evaluate Normalization of Morning Testosterone Levels in Overweight Men With Acquired Hypogonadotropic Hypogonadism and Normal Sperm Concentration
Status: Enrolling
Updated:  9/16/2012
Clinical Research Facility
mi
from
Henderson, NV
Phase III Study to Evaluated Morning Testosterone Normalization in Overweight Men Less Than 60 Years of Age With Secondary Hypogonadism
A Randomized, Double Blind, Placebo Controlled Multi-Center Phase III Study to Evaluate Normalization of Morning Testosterone Levels in Overweight Men With Acquired Hypogonadotropic Hypogonadism and Normal Sperm Concentration
Status: Enrolling
Updated: 9/16/2012
Clinical Research Facility
mi
from
Henderson, NV
Click here to add this to my saved trials
Phase III Study to Evaluated Morning Testosterone Normalization in Overweight Men Less Than 60 Years of Age With Secondary Hypogonadism
A Randomized, Double Blind, Placebo Controlled Multi-Center Phase III Study to Evaluate Normalization of Morning Testosterone Levels in Overweight Men With Acquired Hypogonadotropic Hypogonadism and Normal Sperm Concentration
Status: Enrolling
Updated:  9/16/2012
Clinical Research Facility
mi
from
Newark, NJ
Phase III Study to Evaluated Morning Testosterone Normalization in Overweight Men Less Than 60 Years of Age With Secondary Hypogonadism
A Randomized, Double Blind, Placebo Controlled Multi-Center Phase III Study to Evaluate Normalization of Morning Testosterone Levels in Overweight Men With Acquired Hypogonadotropic Hypogonadism and Normal Sperm Concentration
Status: Enrolling
Updated: 9/16/2012
Clinical Research Facility
mi
from
Newark, NJ
Click here to add this to my saved trials
Phase III Study to Evaluated Morning Testosterone Normalization in Overweight Men Less Than 60 Years of Age With Secondary Hypogonadism
A Randomized, Double Blind, Placebo Controlled Multi-Center Phase III Study to Evaluate Normalization of Morning Testosterone Levels in Overweight Men With Acquired Hypogonadotropic Hypogonadism and Normal Sperm Concentration
Status: Enrolling
Updated:  9/16/2012
Clinical Research Facility
mi
from
New York, NY
Phase III Study to Evaluated Morning Testosterone Normalization in Overweight Men Less Than 60 Years of Age With Secondary Hypogonadism
A Randomized, Double Blind, Placebo Controlled Multi-Center Phase III Study to Evaluate Normalization of Morning Testosterone Levels in Overweight Men With Acquired Hypogonadotropic Hypogonadism and Normal Sperm Concentration
Status: Enrolling
Updated: 9/16/2012
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Phase III Study to Evaluated Morning Testosterone Normalization in Overweight Men Less Than 60 Years of Age With Secondary Hypogonadism
A Randomized, Double Blind, Placebo Controlled Multi-Center Phase III Study to Evaluate Normalization of Morning Testosterone Levels in Overweight Men With Acquired Hypogonadotropic Hypogonadism and Normal Sperm Concentration
Status: Enrolling
Updated:  9/16/2012
Clinical Research Facility
mi
from
Charleston, SC
Phase III Study to Evaluated Morning Testosterone Normalization in Overweight Men Less Than 60 Years of Age With Secondary Hypogonadism
A Randomized, Double Blind, Placebo Controlled Multi-Center Phase III Study to Evaluate Normalization of Morning Testosterone Levels in Overweight Men With Acquired Hypogonadotropic Hypogonadism and Normal Sperm Concentration
Status: Enrolling
Updated: 9/16/2012
Clinical Research Facility
mi
from
Charleston, SC
Click here to add this to my saved trials
Phase III Study to Evaluated Morning Testosterone Normalization in Overweight Men Less Than 60 Years of Age With Secondary Hypogonadism
A Randomized, Double Blind, Placebo Controlled Multi-Center Phase III Study to Evaluate Normalization of Morning Testosterone Levels in Overweight Men With Acquired Hypogonadotropic Hypogonadism and Normal Sperm Concentration
Status: Enrolling
Updated:  9/16/2012
Clinical Research Facility
mi
from
Dallas, TX
Phase III Study to Evaluated Morning Testosterone Normalization in Overweight Men Less Than 60 Years of Age With Secondary Hypogonadism
A Randomized, Double Blind, Placebo Controlled Multi-Center Phase III Study to Evaluate Normalization of Morning Testosterone Levels in Overweight Men With Acquired Hypogonadotropic Hypogonadism and Normal Sperm Concentration
Status: Enrolling
Updated: 9/16/2012
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Phase III Study to Evaluated Morning Testosterone Normalization in Overweight Men Less Than 60 Years of Age With Secondary Hypogonadism
A Randomized, Double Blind, Placebo Controlled Multi-Center Phase III Study to Evaluate Normalization of Morning Testosterone Levels in Overweight Men With Acquired Hypogonadotropic Hypogonadism and Normal Sperm Concentration
Status: Enrolling
Updated:  9/16/2012
Clinical Research Facility
mi
from
Salt Lake City, UT
Phase III Study to Evaluated Morning Testosterone Normalization in Overweight Men Less Than 60 Years of Age With Secondary Hypogonadism
A Randomized, Double Blind, Placebo Controlled Multi-Center Phase III Study to Evaluate Normalization of Morning Testosterone Levels in Overweight Men With Acquired Hypogonadotropic Hypogonadism and Normal Sperm Concentration
Status: Enrolling
Updated: 9/16/2012
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Effects of PPAR Ligands on Ectopic Fat Accumulation and Inflammation
Effects of PPAR Ligands on Ectopic Fat Accumulation and Inflammation in Subjects With Impaired Glucose Tolerance
Status: Enrolling
Updated:  10/2/2012
VA Eastern Colorado Health Care System, Denver
mi
from
Denver, CO
Effects of PPAR Ligands on Ectopic Fat Accumulation and Inflammation
Effects of PPAR Ligands on Ectopic Fat Accumulation and Inflammation in Subjects With Impaired Glucose Tolerance
Status: Enrolling
Updated: 10/2/2012
VA Eastern Colorado Health Care System, Denver
mi
from
Denver, CO
Click here to add this to my saved trials
A Study to Determine the Effectiveness of Escalating Doses of RAD001 (Everolimus) in Patients With Lymphangioleiomyomatosis
An Exploratory, Open Label, Non-randomized, Within-patient Multiple Dose-escalation Safety, Tolerability, PK and Efficacy Trial of RAD001 (Everolimus) in Patients With Lymphangioleiomyomatosis
Status: Enrolling
Updated:  10/22/2012
Center for LAM Research and Clinical Care
mi
from
Boston, MA
A Study to Determine the Effectiveness of Escalating Doses of RAD001 (Everolimus) in Patients With Lymphangioleiomyomatosis
An Exploratory, Open Label, Non-randomized, Within-patient Multiple Dose-escalation Safety, Tolerability, PK and Efficacy Trial of RAD001 (Everolimus) in Patients With Lymphangioleiomyomatosis
Status: Enrolling
Updated: 10/22/2012
Center for LAM Research and Clinical Care
mi
from
Boston, MA
Click here to add this to my saved trials
A Study to Determine the Effectiveness of Escalating Doses of RAD001 (Everolimus) in Patients With Lymphangioleiomyomatosis
An Exploratory, Open Label, Non-randomized, Within-patient Multiple Dose-escalation Safety, Tolerability, PK and Efficacy Trial of RAD001 (Everolimus) in Patients With Lymphangioleiomyomatosis
Status: Enrolling
Updated:  10/22/2012
University of Cincinnati - Department of Internal Medicine Pulmonary, Critical Care & Sleep Medicine
mi
from
Cincinnati, OH
A Study to Determine the Effectiveness of Escalating Doses of RAD001 (Everolimus) in Patients With Lymphangioleiomyomatosis
An Exploratory, Open Label, Non-randomized, Within-patient Multiple Dose-escalation Safety, Tolerability, PK and Efficacy Trial of RAD001 (Everolimus) in Patients With Lymphangioleiomyomatosis
Status: Enrolling
Updated: 10/22/2012
University of Cincinnati - Department of Internal Medicine Pulmonary, Critical Care & Sleep Medicine
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Study to Determine the Effectiveness of Escalating Doses of RAD001 (Everolimus) in Patients With Lymphangioleiomyomatosis
An Exploratory, Open Label, Non-randomized, Within-patient Multiple Dose-escalation Safety, Tolerability, PK and Efficacy Trial of RAD001 (Everolimus) in Patients With Lymphangioleiomyomatosis
Status: Enrolling
Updated:  10/22/2012
Novartis Investigative Site
mi
from
Lyon,
A Study to Determine the Effectiveness of Escalating Doses of RAD001 (Everolimus) in Patients With Lymphangioleiomyomatosis
An Exploratory, Open Label, Non-randomized, Within-patient Multiple Dose-escalation Safety, Tolerability, PK and Efficacy Trial of RAD001 (Everolimus) in Patients With Lymphangioleiomyomatosis
Status: Enrolling
Updated: 10/22/2012
Novartis Investigative Site
mi
from
Lyon,
Click here to add this to my saved trials
Leptin Levels in Papillary Thyroid Cancer
Assessment of Serum Leptin Levels in Females With Papillary Thyroid Carcinoma, Benign Thyroid Nodules, and Normal Controls
Status: Enrolling
Updated:  10/29/2012
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Leptin Levels in Papillary Thyroid Cancer
Assessment of Serum Leptin Levels in Females With Papillary Thyroid Carcinoma, Benign Thyroid Nodules, and Normal Controls
Status: Enrolling
Updated: 10/29/2012
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Click here to add this to my saved trials
Differential Effects of rhGH vs. rhIGF-1 on Cardiovascular Risk Factors
Differential Effects of rhGH vs. rhIGF-1 on Cardiovascular Risk Factors in Adult Patients With Growth Hormone Deficiency
Status: Enrolling
Updated:  11/2/2012
Columbia University College of Physicians and Surgeons
mi
from
New York, NY
Differential Effects of rhGH vs. rhIGF-1 on Cardiovascular Risk Factors
Differential Effects of rhGH vs. rhIGF-1 on Cardiovascular Risk Factors in Adult Patients With Growth Hormone Deficiency
Status: Enrolling
Updated: 11/2/2012
Columbia University College of Physicians and Surgeons
mi
from
New York, NY
Click here to add this to my saved trials
Effects of Glimepiride on Recovery From Hypoglycemia in Participants With Type 2 Diabetes Mellitus (MK-0000-253)
A Study to Assess the Effects of Glimepiride on Recovery From Hypoglycemia in Participants With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  11/9/2012
Clinical Research Facility
mi
from
Encino, CA
Effects of Glimepiride on Recovery From Hypoglycemia in Participants With Type 2 Diabetes Mellitus (MK-0000-253)
A Study to Assess the Effects of Glimepiride on Recovery From Hypoglycemia in Participants With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/9/2012
Clinical Research Facility
mi
from
Encino, CA
Click here to add this to my saved trials
Outpatient Pump Shutoff Pilot Feasibility and Efficacy Study
Reduction of Nocturnal Hypoglycemia by Using Predictive Algorithms and Pump Suspension: An Outpatient Pilot Feasibility and Efficacy Study
Status: Enrolling
Updated:  11/28/2012
Stanford University
mi
from
Stanford, CA
Outpatient Pump Shutoff Pilot Feasibility and Efficacy Study
Reduction of Nocturnal Hypoglycemia by Using Predictive Algorithms and Pump Suspension: An Outpatient Pilot Feasibility and Efficacy Study
Status: Enrolling
Updated: 11/28/2012
Stanford University
mi
from
Stanford, CA
Click here to add this to my saved trials
Outpatient Pump Shutoff Pilot Feasibility and Efficacy Study
Reduction of Nocturnal Hypoglycemia by Using Predictive Algorithms and Pump Suspension: An Outpatient Pilot Feasibility and Efficacy Study
Status: Enrolling
Updated:  11/28/2012
Barbara Davis Center for Childhood Diabetes
mi
from
Denver, CO
Outpatient Pump Shutoff Pilot Feasibility and Efficacy Study
Reduction of Nocturnal Hypoglycemia by Using Predictive Algorithms and Pump Suspension: An Outpatient Pilot Feasibility and Efficacy Study
Status: Enrolling
Updated: 11/28/2012
Barbara Davis Center for Childhood Diabetes
mi
from
Denver, CO
Click here to add this to my saved trials
The Efficacy of CASAD in Patients With Diarrhea Related to Medullary Thyroid Cancer
The Efficacy of CASAD in Patients With Diarrhea Related to Medullary Thyroid Cancer
Status: Enrolling
Updated:  11/29/2012
M.D. Anderson Cancer Center
mi
from
Houston, TX
The Efficacy of CASAD in Patients With Diarrhea Related to Medullary Thyroid Cancer
The Efficacy of CASAD in Patients With Diarrhea Related to Medullary Thyroid Cancer
Status: Enrolling
Updated: 11/29/2012
M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Effect of Caloric Restriction on Fat Oxidation in Obese Men and Women (Magellan II)
Effect of Caloric Restriction on Metabolic Biomarkers and Fat Oxidation in Obese Men and Women (Magellan II)
Status: Enrolling
Updated:  12/5/2012
Translational Research Institute for Metabolism and Diabetes
mi
from
Orlando, FL
Effect of Caloric Restriction on Fat Oxidation in Obese Men and Women (Magellan II)
Effect of Caloric Restriction on Metabolic Biomarkers and Fat Oxidation in Obese Men and Women (Magellan II)
Status: Enrolling
Updated: 12/5/2012
Translational Research Institute for Metabolism and Diabetes
mi
from
Orlando, FL
Click here to add this to my saved trials
Exercise Dose-Response Effects in Prediabetes
Exercise Dose-Response Effects in Prediabetes: Responses and Mechanisms
Status: Enrolling
Updated:  12/10/2012
Duke Center For Living
mi
from
Durham, NC
Exercise Dose-Response Effects in Prediabetes
Exercise Dose-Response Effects in Prediabetes: Responses and Mechanisms
Status: Enrolling
Updated: 12/10/2012
Duke Center For Living
mi
from
Durham, NC
Click here to add this to my saved trials
A Study to Evaluate Sildenafil for the Treatment of Lymphatic Malformations
An Investigational Pilot Study to Evaluate Sildenafil for the Treatment of Lymphatic Malformations
Status: Enrolling
Updated:  12/13/2012
Stanford University School of Medicine
mi
from
Stanford, CA
A Study to Evaluate Sildenafil for the Treatment of Lymphatic Malformations
An Investigational Pilot Study to Evaluate Sildenafil for the Treatment of Lymphatic Malformations
Status: Enrolling
Updated: 12/13/2012
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Screening for Prediabetes
Screening for Prediabetes and Early Diabetes in Primary Care
Status: Enrolling
Updated:  12/17/2012
Atlanta VA Medical and Rehab Center, Decatur
mi
from
Decatur, GA
Screening for Prediabetes
Screening for Prediabetes and Early Diabetes in Primary Care
Status: Enrolling
Updated: 12/17/2012
Atlanta VA Medical and Rehab Center, Decatur
mi
from
Decatur, GA
Click here to add this to my saved trials
Glycemic Load & Resistance Training on Endothelial Function & Insulin Sensitivity
Glycemic Load & Resistance Training on Endothelial Function & Insulin Sensitivity
Status: Enrolling
Updated:  12/19/2012
University of California at Los Angeles
mi
from
Los Angeles, CA
Glycemic Load & Resistance Training on Endothelial Function & Insulin Sensitivity
Glycemic Load & Resistance Training on Endothelial Function & Insulin Sensitivity
Status: Enrolling
Updated: 12/19/2012
University of California at Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Metformin for the Treatment of Premature Pubarche in Girls
A Double Blind Randomized Controlled 12 Month Trial of Metformin for the Treatment of Premature Pubarche in Girls
Status: Enrolling
Updated:  12/20/2012
Riley Hospital for Children : Indiana University School of Medicine
mi
from
Indianapolis, IN
Metformin for the Treatment of Premature Pubarche in Girls
A Double Blind Randomized Controlled 12 Month Trial of Metformin for the Treatment of Premature Pubarche in Girls
Status: Enrolling
Updated: 12/20/2012
Riley Hospital for Children : Indiana University School of Medicine
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Metformin for the Treatment of Premature Pubarche in Girls
A Double Blind Randomized Controlled 12 Month Trial of Metformin for the Treatment of Premature Pubarche in Girls
Status: Enrolling
Updated:  12/20/2012
Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Metformin for the Treatment of Premature Pubarche in Girls
A Double Blind Randomized Controlled 12 Month Trial of Metformin for the Treatment of Premature Pubarche in Girls
Status: Enrolling
Updated: 12/20/2012
Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials